1. Introduction {#s0005}
===============

The most common cause of obstruction in old man was observed in benign prostatic hyperplasia (BPH). BPH shows a prostatic enlargement ([@b0060], [@b0100]). Previous study reported that neurological factors contributed to smooth muscle dysfunction as risk factor in the development of symptoms of LUTS ([@b0140]).

The regulation of micturition links between various regions in the brainstem and extensive tracts ([@b0065]). Many neurons in the brainstem regions are involved in the regulation of the micturition ([@b0125]). The PMC plays an important role in controlling urinary bladder function ([@b0065], [@b0145]). Stimulation of neurons in the PMC region contributed to bladder contractions, relaxation of the bladder neck, and external urethral sphincter ([@b0030]), which results in micturition. And periaqueductal gray (PAG) and medial preopticnucleus (MPA) reported the relationship with PMC ([@b0020]). PAG and MPA regions of the hypothalamus in the brain associated with the control of urinary bladder function. The connection between PAG and PMC also is contributed to micturition reflex ([@b0045], [@b0020], [@b0125]). And the ventrolateral PAG (vlPAG) plays an important role in micturition reflex ([@b0020], [@b0095]). It was reported that electrical or chemical stimulation in the LUT showed changes in neuronal activity ([@b0025], [@b0015]).

Several studies reported that nerve growth factor (NGF) was related to the control of micturition ([@b0040], [@b0035]). And Stimulation of the bladder increased expressions of NGF in the PAG, PMC, and spinal cord ([@b0050], [@b0070]). NGF also is an important modulator of voiding. It is released in the spinal cord or the urinary bladder ([@b0130]). The NGF has been used to assess neuronal activity ([@b0090]).

Previous study showed that the *Panax ginseng* CAMAYER (*P. ginseng*) protected development of prostate in the rats ([@b0075], [@b0080], [@b0085], [@b0110], [@b0115]). However, PMC, vlPAG, and MPA regions in the brain have not been investigated. The present study explores the influences of *P. ginseng* on NGF expression in the brain.

2. Material and methods {#s0010}
=======================

2.1. Reagents and chemicals {#s0015}
---------------------------

The reagents and chemicals used in this study were procured from the Sigma chemicals (USA). All the reagents and chemical used were of analytical grade.

2.2. Preparation of the *P. ginseng* {#s0020}
------------------------------------

*P. ginseng* was kindly gifted from the Department of Medicinal Crop Research (Eumsung-gun, Chungbuk, Korea) ([@b0075], [@b0080], [@b0085]).

2.3. Animals {#s0025}
------------

7 week male Wistar rats with an average body weight of 250 ± 10 g were purchased from Central Lab Animal Inc, Korea for the present study. The in vivo and other experiments were performed according the standard methodology of the Korean National Health Institute of Health Animal Facility and it was authenticated and confirmed by the ethical committee of Kyung Hee University.

2.4. Induction of BPH and treatments {#s0030}
------------------------------------

Firstly, the rats were operated for orchiectomy, except the control group. After orchiectomy, they were randomly assigned to the following groups: (A) control group; (B) BPH induced testosterone group; (C) BPH-induced and *P. ginseng*-treated group, 200 mg/kg, administered orally; (D) BPH-induced and finasteride-treated group as the positive treated control. The materials were supplemented to the animal every day up to four weeks. After 4 weeks, all rats in the four groups were sacrificed and fresh prostate was selected for the micromorphological studies.

2.5. Immunohistochemistry (IHC) {#s0035}
-------------------------------

The brain of rats were cut into 35 μm thick paraffin-sections using microtome. The sections were attached on slide. Reagents such as peroxides quenching with 3% H~2~O~2~, primary NGF antibody, biotinylated secondary antibodies (1: 1000), phosphate buffer saline, streptavidin--HRP and diaminobenzidinetetrahydrochloride (DAB) were used. The images were noted at 100×.

2.6. Statistical analyses {#s0040}
-------------------------

Standard error and mean were calculated for all the experiments. ANOVA and Tukey test were applied to evaluate significant differences between the groups. All statistical analyses were done using the SPSS for Windows (Micro Soft, USA).

3. Results {#s0045}
==========

3.1. Effect of *Panax ginseng* on prostatic hyperplasia {#s0050}
-------------------------------------------------------

Photomicrographs of NGF-positive cells in MPA, vlPAG, and PMC regions are shown in [Figure 1](#f0005){ref-type="fig"}, [Figure 2](#f0010){ref-type="fig"}, [Figure 3](#f0015){ref-type="fig"}. The NGF expression by IHC showed spots with dark brown color. In the MPA region, the number of NGF-positive cells was 33.66 ± 4.03/section in the control group, 81.75 ± 3.28/section in the BPH-induced group,65.00 ± 5.34/section in the BPH-induced and *P. ginseng*-treated group, and 68.50 ± 4.78/section in the BPH-induced and finasteride-treated group ([Fig. 1](#f0005){ref-type="fig"}). In the vlPAG region, the number of NGF-positive cells was 41.66 ± 4.67/section in the control group, 104.25 ± 4.75/section in the BPH-induced group,77.91 ± 5.13/section in the BPH-induced and *P. ginseng*-treated group, and 81.00 ± 5.78/section in the BPH-induced and finasteride-treated group ([Fig. 2](#f0010){ref-type="fig"}). In the PMC region, the number of NGF-positive cells was 35.33 ± 3.69/section in the control group, 77.75 ± 4.87/section in the BPH-induced group,58.58 ± 4.24/section in the BPH-induced and *P. ginseng*-treated group, and 60.66 ± 3.93/section in the BPH-induced and finasteride-treated group ([Fig. 3](#f0015){ref-type="fig"}). The present results revealed that NGF expressions were increased in testosterone induced BPH in Wistar rats (*P* \< 0.05). The increased NGF expression in MPA, vlPAG, and PMC regions showed that *P. ginseng* treatment significantly decreased (*P* \< 0.05).Figure 1NGF expressions in MPA region of the neuronal voiding centers. The sections were stained for NGF immunoreactivity (brown). The scale bar represents 150 μm. (A) Control group (B) BPH-induced group (C) BPH-induced and *P. ginseng*-treated group (D) BPH-induced and finasteride-treated group. Upper: Photomicrographs of NGF-positive cells in the neuronal voiding centers. Lower: Number of NGF-positive cells in each group. ^\*^Represents *P* \< 0.05 compared to the control group. ^\#^Represents *P* \< 0.05 compared to the BPH-induced group.Figure 2NGF expressions in vlPAG region of the neuronal voiding centers. The sections were stained for NGF immunoreactivity (brown). The scale bar represents 150 μm. (A) Control group (B) BPH-induced group (C) BPH-induced and *P. ginseng*-treated group (D) BPH-induced and finasteride-treated group. Upper: Photomicrographs of NGF-positive cells in the neuronal voiding centers. Lower: Number of NGF-positive cells in each group. ^\*^Represents *P* \< 0.05 compared to the control group. ^\#^Represents *P* \< 0.05 compared to the BPH-induced group.Figure 3NGF expressions in PMC region of the neuronal voiding centers. The sections were stained for NGF immunoreactivity (brown). The scale bar represents 150 μm. (A) Control group (B) BPH-induced group (C) BPH-induced and *P. ginseng*-treated group (D) BPH-induced and finasteride-treated group. Upper: Photomicrographs of NGF-positive cells in the neuronal voiding centers. Lower: Number of NGF-positive cells in each group. ^\*^Represents *P* \< 0.05 compared to the control group. ^\#^Represents *P* \< 0.05 compared to the BPH-induced group.

4. Discussion {#s0055}
=============

In recent study, we reported the influence of *P. ginseng* on testosterone ([@b0075]). The study revealed that *P. ginseng* treatment significantly decreased prostate size and prostate weight compared to those of the normal group. Additionally, *P*. *ginseng* decreased the expression of EGFR and BCL2 in prostate tissue ([@b0075]). The results suggested that *P. ginseng* may have inhibited alpha-1-adrenergic receptor and suppressed BPH development in the studied rats. However, previous study did not investigate whether many neuron regions involved in the control of the bladder, such as PMC, MPA, and vlPAG, were related to *P. ginseng* treatment. The present study evaluated the effects of *P. ginseng* on NGF including PMC, MPA, and vlPAG.

The results of the present study showed that NGF expression in PMC, MPA, and vlPAG regions of brainstem were increased in the BPH group compared to those of the normal group. The increased NGF expression in PMC, MPA, and vlPAG significantly showed decrease in *P. ginseng* treatment group. Overactive bladder (OAB), known as OAB syndrome, is characterized by involuntary bladder contraction ([@b0120]). The OAB can lead to the development of BPH. Previous study showed that the incidence of OAB associated with BPH is around 40--75% ([@b0010], [@b0005]). The storage sub-classification category of LUTS is the same as the OAB ([@b0135]). Several studies suggested that micturition involves process connection between urinary tract and neurons of brainstem. The NGF has been known as an important modulator of urinary bladder (the storage and voiding of urine). NGF is observed by urothelial tissue and smooth muscle cells. It is one of neurotrophins. It is reported that NGF was involved in the neuro plasticity pathways ([@b0105]). The level of NGF elevated in condition with LUT. Recently, Ergin et al. suggested the NGF level in urine could be used for diagnosis and assessment of dysfunctional voiding, as biomarkers ([@b0055]). The central NGF production in the injured spinal cord could regulate micturition ([@b0105]).

5. Conclusion {#s0060}
=============

In summary, we confirmed that *P. ginseng* has inhibited effect to develop prostate hyperplasia and prostate weight. Among neuron regions involved in the control of the bladder, PMC, MPA, and vlPAG regions showed that NGF expressions were increased in BPH. And *P. ginseng* significantly decreased the increased NGF expressions in three regions. Thus, these results suggested that *P. ginseng* could be used as an effective treatment to inhibit BPH. The inhibited effect of *P. ginseng* may be associated with modulation NGF expressions in PMC, MPA, and vlPAG regions of the brain.
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